Therefore, we suggest to screen MOG-ab in patients with progressive cognitive or psychiatric symptoms and leukodystrophy-like MRI pattern to differentiate cMOG-E from untreatable diseases, which may facilitate treatment decision and prognosis. This evidence concerns the gene MOG and leukodystrophy.